Marks LB - Search Results

1

Role of lymphangiography in staging testicular seminoma.

Marks LB, Shipley WU, Walker TG, Waltman AC. Marks LB, et al. Urology. 1991 Sep;38(3):264-6. doi: 10.1016/s0090-4295(91)80360-j. Urology. 1991. PMID: 1887542

2

The role of radiotherapy in patients with advanced seminomatous germ cell tumors. Controversies in management. Part 2.

Anscher MS, Marks LB, Shipley WU. Anscher MS, et al. Among authors: marks lb. Oncology (Williston Park). 1992 Aug;6(8):97-104; discussion 107-8, 110. Oncology (Williston Park). 1992. PMID: 1323989 Review.

3

Radiation therapy for testicular seminoma: controversies in the management of early-stage disease.

Marks LB, Anscher MS, Shipley WU. Marks LB, et al. Oncology (Williston Park). 1992 Jun;6(6):43-8; discussion 51-2. Oncology (Williston Park). 1992. PMID: 1535210

4

The role of radiation therapy in the treatment of testicular germ cell tumors.

Marks LB, Anscher MS, Shipley WU. Marks LB, et al. Hematol Oncol Clin North Am. 1991 Dec;5(6):1143-72. Hematol Oncol Clin North Am. 1991. PMID: 1663938 Review.

5

Testicular seminoma: clinical and pathological features that may predict para-aortic lymph node metastases.

Marks LB, Rutgers JL, Shipley WU, Walker TG, Stracher MS, Waltman AC, Geller SC. Marks LB, et al. J Urol. 1990 Mar;143(3):524-7. doi: 10.1016/s0022-5347(17)40008-5. J Urol. 1990. PMID: 2304164

6

Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, upfront MCV (methotrexate, cisplatin, and vinblastine) chemotherapy and pelvic irradiation plus cisplatin.

Marks LB, Kaufman SD, Prout GR Jr, Heney NM, Griffin PP, Shipley WU. Marks LB, et al. Int J Radiat Oncol Biol Phys. 1988 Oct;15(4):877-83. doi: 10.1016/0360-3016(88)90121-6. Int J Radiat Oncol Biol Phys. 1988. PMID: 3182328

7

Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: is a posterior axillary boost field necessary?

Bentel GC, Marks LB, Hardenbergh PH, Prosnitz LR. Bentel GC, et al. Among authors: marks lb. Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):755-8. doi: 10.1016/s0360-3016(00)00485-5. Int J Radiat Oncol Biol Phys. 2000. PMID: 10837961

8

Radiation dose-volume effects of the urinary bladder.

Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Viswanathan AN, et al. Among authors: marks lb. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S116-22. doi: 10.1016/j.ijrobp.2009.02.090. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171505 Free PMC article. Review.

9

Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.

Pepek JM, Marks LB, Berry MF, Ready NE, Gee NG, Coleman RE, D'Amico TA, Crawford J, Kelsey CR. Pepek JM, et al. Among authors: marks lb. Pract Radiat Oncol. 2015 Mar-Apr;5(2):79-84. doi: 10.1016/j.prro.2014.05.002. Epub 2014 Jun 14. Pract Radiat Oncol. 2015. PMID: 25413417

10

The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram.

Marks LB, Spencer DP, Sherouse GW, Bentel G, Clough R, Vann K, Jaszczak R, Coleman RE, Prosnitz LR. Marks LB, et al. Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):65-75. doi: 10.1016/0360-3016(95)00091-C. Int J Radiat Oncol Biol Phys. 1995. PMID: 7642433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters